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Serotonin transporter clustering is an important feature for regulation of this transporter activity. We used immunocytochemistry
to analyze alterations in serotonin transporter clustering in blood lymphocytes of reeler mice. Serotonin transporter
immunolabelling is observed mostly as a patchy staining in lymphocytes membranes. Comparison of the number and size of
serotonin transporter clusters in wild-type mice, heterozygous reeler mice, and homozygous reeler mice showed an increase in the
number and size of clusters in heterozygous reeler mice, but only an increase in clusters size in homozygous reeler mice. Reelin
is down-regulated in the brain of schizophrenia, autism, and mood disorders, and is also expressed in blood plasma. There is
the possibility therefore that alterations in serotonin transporter clustering in blood lymphocytes associated with a decrease in
reelin expression may be operative in some cardiovascular or immune system alterations showing comorbidity with these mental
disorders.
1.Introduction
Protein clustering into speciﬁc membrane domains is known
to be of importance for membrane proteins functional
regulation: the clustering of neurotransmitter receptors into
postsynapticactivesites,theformationoftheimmunological
synapse, the partitioning of membrane proteins into lipid
raft domains, and the clustering of membrane proteins to be
internalized are good examples of that.
The serotonin transporter (SERT) belongs to the SLC6
family of sodium- and chloride-dependent integral mem-
brane proteins, and is the primary responsible for the
recapture of released serotonin from the extracellular space
[1, 2]. The clustering of SERT into speciﬁc membrane
domains such as lipid rafts [3], SERT oligomerization [4, 5],
and SERT subcellular distribution [6] appears to be critical
for serotonin reuptake activity. SERT is one of the main
targetsofantidepressantmedication,andalterationsinSERT
expression and activity have been found both in mood and
psychotic disorders. In fact, a decrease in SERT binding in
blood platelets is one of the best-characterized biomarkers of
depression [7], and a similar decrease has also been found in
peripheral lymphocytes in depression [8–10].
Reelin is a large extracellular matrix protein abundant
in brain tissue whose levels are down-regulated in several
psychiatric disorders [11–15]. Reelin is also expressed in
blood plasma [16], and alterations in reelin plasma lev-
e l sa r ea l s of o u n di nd i ﬀerent psychiatric disorders such
as schizophrenia, mood disorders, and autism [14, 17],
although an accurate measurement of reelin plasma levels is
not easily accomplished due to its sensitivity to proteolysis
and freeze-thawing cycles [18].
The primary actions of reelin in the nervous systems
are regulating neural migration and synaptogenesis in cor-
tical areas during brain development (i.e., cerebral cortex,
hippocampus, olfactory bulb, and cerebellum), and later
in stabilizing synaptic contacts onto dendritic spines in
the adult brain thereby regulating synaptic plasticity (see
[19–21]). These actions are mediated at the molecular
level by the interaction of reelin with ApoER2-VLDLR
receptors, and bring about the phosphorylation of the
adaptorproteinDAB1andactivationofnonreceptortyrosine2 Cardiovascular Psychiatry and Neurology
kinases (see as reviews [20, 21]). In addition, reelin also
binds integrin receptors resulting in the upregulation of
speciﬁc mRNAs translation in dendritic spines [22], and
an increase in number and clustering of intramembrane
particles (i.e., transmembrane proteins) in postsynaptic
membrane domains [23].
While reelin actions in the nervous system are well
studied, there is not so much knowledge about the possible
actions of reelin in blood plasma, although it is known
that reelin plasma is mostly secreted by hepatocytes [16],
and is processed by plasminogen activator and plasmin
[18].
Homozygous reeler mice (Reln
−/−) show no detectable
levels of reelin in plasma, while the happloinssuﬁcient het-
erozygous reeler mice (Reln
+/−) express reelin plasma levels
about one half of those in wild-type (Reln
+/+)l i t t e r m a t e s
[16],becomingagoodmodeltoanalyzetheeﬀectsthatreelin
down-regulation or null expression may induce in blood
cells.
In the present report, we hypothesize that reelin may
have an inﬂuence in clustering of membrane proteins in
lymphocytes, and analyze the alterations observed in the
clustering of SERT in peripheral lymphocytes in Reln
+/− and
Reln
−/− mice, in comparison to Reln
+/+ mice.
2.MaterialsandMethods
2.1. Animals and Collection of Lymphocytes. We have used
a total of 48 adult male mice in this experiment: 16 wild-
type mice (Reln
+/+), 16 heterozygous reeler mice (Reln
+/−),
and 16 reeler mice (Reln
−/−). The animals were obtained
from heterozygous breeding pairs (Jackson Laboratory, Bar
Harbor, ME). Genotyping was performed by PCR using
the following primers: 5  TAATCTGTCCTCACTCGTCC 3 ,
3  ACAGTTGACATACCTTAATC 5 ,3   TGCATTAATGTC-
GACTGTTGT 5 . The PCR products were subsequently
analyzed in a gel of 2% agarose.
Animal handling and maintenance, as well as all experi-
mental procedures, were conducted in accordance with the
European Communities Council Directive of 24 Novem-
ber 1986 (86/609/EEC) and Spanish Royal Decree of 14
March 1988 (223/1988/BOE). The performed experiments
also received the approval of the ethics committee of the
University of Santiago de Compostela.
Mice were anesthetized by IP injection of 15% chloral
hydrate.Bloodwascollectedfromtheorbitsafterenucleation
of the eyes, followed by euthanasia by cervical dislocation.
This procedure allowed to obtain up to 1mL of blood per
animalthatwascollectedwithACDasanticoagulant(85mM
trisodium citrate, 65mM citric acid, 111mM anhydrous
glucose), at a ratio 1 : 6 (v/v). Blood samples diluted 1 : 1
in 0.9% NaCl were centrifuged in a Percoll gradient for
20 minutes at 800g, to collect the lymphocytes in the
upper layer of the Percoll gradient. The lymphocytes were
resuspended in saline solution and centrifuged at 1000g
for 10 minutes. After repeating the procedure, cells were
resuspended in 1mL of saline solution, and ﬁxed for 1
minute in a solution of 1% paraformaldehyde in phosphate
buﬀer at RT. Afterwards, cells were maintained for up to one
week at 4◦C in 1mL of saline solution.
2.2. Immunocytochemistry. Immunolabelling of SERT was
performed by consecutive centrifugation and resuspension
of the lymphocyte samples in every step. The procedure
involved ﬁrst the incubation of the samples for 10 minutes at
4◦C, in a solution of 100mL of mice IgG (Sigma), diluted in
PBS with 1%BSA, to block membrane immunoglobulins. It
followedtheincubationfor12hoursat4◦Cwithasolutionof
the primary antibody (Rabbit anti SERT, Chemicon) diluted
1 : 100 in PBS with 1%BSA. After washing, the samples
were incubated in the dark, for 1 hour at RT with the
secondary antibody (Goat antirabbit conjugated with Alexa
Fluor 488, Molecular Probes) diluted 1 : 200 in PBS with
1%BSA. After repeated washing, samples were extended on
slides and coverslipped and mounted with Moviol medium
(Calbiochem).Thesamplesweremaintainedat−20
◦C,untill
analysis by confocal microscopy.
Samples were studied and lymphocyte photographs
obtained in a laser confocal microscope Leica TCS-SP2.
Photomicrographs were collected of 100 lymphocytes per
sample. Control experiments by omitting the primary anti-
body resulted in a lack of immunoreactivity.
2.3. Data Analysis and Statistics. SERT labelling as obtained
in confocal micrographs was analyzed by using ImageJ
1.42 imaging software (National Institutes of Health). The
number of lymphocytes analyzed was 100 per animal (16
animals per group). The imaging system allowed carrying
out an automatic counting of the number of SERT clusters
per lymphocyte, of the size of those clusters, and also the
percentage of the lymphocytes surface occupied by those
clusters.Inaddition,thesystemallowedperformingasurface
plot indicating the intensity of ﬂuorescence labeling per
cluster. Statistical analysis was done using One way ANOVA
followed by Kruskal-Wallis posthoc test. The statistical
signiﬁcance was established at P<. 05.
3. Results
SERT immunolabelling is mostly evidenced as immunoﬂu-
orescent clusters observed primarily in the lymphocytes
plasma membrane (Figures 1(a), 1(c),a n d1(e)).
The direct observation of SERT immunolabelling in
lymphocytes of reeler mice shows that SERT clusters are
more clearly seen in Reln
+/+ mice lymphocytes, while in both
Reln
+/− and Reln
−/− mice lymphocytes, SERT staining is
more fuzzy and of a lower intensity, as can be seen in surface
plot images (Figures 1(a)–1(f)).
Statistical analysis of data indicates that the number of
SERT immunopositive clusters per lymphocyte is increased
about 50% in Reln
+/− mice in comparison with wild-type
mice (Figure 2(a) and Table 1), while in Reln
−/− mice the
number of SERT immunopositive clusters is similar to that
of wild-type mice, and therefore, lower than in Reln
+/− mice
(Figure 2(a) and Table 1).Cardiovascular Psychiatry and Neurology 3
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Figure 1: Confocal micrographs (a, c, e) and surface plot graphs (b, d, f) of examples of blood lymphocytes from wild-type (Reln
+/+),
heterozygous (Reln
+/−), and reeler (Reln
−/−) mice. Note the increase in SERT-positive clusters size in heterozygous and reeler mice, as well
as a decrease in the intensity of labelling as seen in the surface plot analysis.
The average size of SERT immunopositive clusters is
increased about 27% in Reln
+/− mice in comparison to wild-
type mice, while in reeler mice (Reln
−/−), the average size
of SERT clusters more than doubles that of wild-type mice
(and increase of 109%), and is about 64% larger than in
heterozygous reeler mice (Reln
+/− (Figure 2(b) and Table 1).
The percentage of the lymphocytes surface occupied by
SERT immunopositive clusters is also increased in both4 Cardiovascular Psychiatry and Neurology
Table 1: Statistical analysis of SERT-positive clusters in blood
lymphocytes of Reln
+/+, Reln
+/−,a n dReln
−/− mice.
SERT clusters Reln
+/+ Reln
+/− Reln
−/−
Number 30.8±1.08 46.7±1.47a 29.3±0.72
Size 0.11±0.003 0.14±0.003b 0.23±0.004c
%o fl y m p h .s u r f a c e 8 . 8 8±0.32 13.3±0.22d 19.5±0.59e
Statistical signiﬁcance set at P<. 05.
a, b, d. Diﬀerent than in Reln+/+ and Reln
−/− mice.
c, e. Diﬀerent than in Reln+/+ and Reln+/− mice.
Reln
+/− mice (a 50% increase) and Reln
−/− mice (an increase
of 119%) with respect to wild-type mice (Figure 2(c) and
Table 1). In addition, there is an increase of about 47% in
the same value in Reln
−/−mice in comparison with Reln
+/−
mice (Figure 2(c) and Table 1).
The graphic representation of the distribution of SERT
clusters size in lymphocytes evidences that about 60% of
the clusters are comprised in the interval of 0.05–0.1μm2 in
wild-typeReln
+/+ mice,whilethispercentageisonlyofabout
40% in lymphocytes of Reln
+/− mice, and 30% in Reln
−/−
mice (Figure 3).
4. Discussion
As far as we know this is the ﬁrst attempt to study alterations
of SERT clustering in blood lymphocytes of reeler mice. The
results show that a down-regulation of about one-half of
plasma reelin levels such as that observed in Reln
+/− mice
brings about an increase in the number of SERT clusters
and also an increase in clusters size, whereas in Reln
−/− mice
(showing null expression of reelin) the number of SERT
clusters is similar to that observed in Reln
+/+ mice, but of
a much larger size than not only those in Reln
+/+ mice, but
also of those in Reln
+/− mice.
In case of a possible replication of these studies, it
is essential to consider the ﬁxative employed, the time of
ﬁxation, and the temperature at which the experiments
were performed, because all of these parameters can aﬀect
the degree of membrane proteins clustering: for example,
experiments of labelling of lipid raft markers showed that
an increase in the amount of ﬁxative tends to reduce the
labelling of membrane markers, while a decrease in the
amount of ﬁxative and/or a decrease in the temperature of
ﬁxation tends to increase the size of lipid raft clusters as
ascertained by immunolabelling [24].
M a n yr e p o r t sh a v ef o c u s s e do nb r a i na n db e h a v i o u r a l
alterations in both reeler and heterozygous reeler mice (see
[25–28]); however, there are no so many studies on blood
cells alterations in reeler mice. Interestingly, a report by
Green-Johnson et al. [29] shows a suppression of T cell and
macrophage function in reeler mice. These authors showed
a decrease in proliferation of CD3-positive splenic T cells in
Reln
−/− mice (but not in Reln
+/− mice) after activation of
the immune system by injection with anti-CD3 antibodies
for three days, and also a decrease in production of IL-
2, IL-4 and interferon in Reln
−/− mice, while there was
0
10
20
30
40
50
60
N
u
m
b
e
r
o
f
S
E
R
T
c
l
u
s
t
e
r
s
p
e
r
l
y
m
p
h
o
c
y
t
e
Reln+/+ Reln+/− Reln−/−
∗
∗
(a)
0
0.05
0.1
0.15
0.2
0.25
S
i
z
e
o
f
S
E
R
T
c
l
u
s
t
e
r
s
p
e
r
l
y
m
p
h
o
c
y
t
e
Reln+/+ Reln+/− Reln−/−
∗
∗
∗
(b)
0
5
10
15
20
25
L
y
m
p
h
o
c
y
t
e
s
s
u
r
f
a
c
e
o
c
c
u
p
i
e
d
b
y
S
E
R
T
c
l
u
s
t
e
r
s
(
%
)
Reln+/+ Reln+/− Reln−/−
∗
∗
∗
(c)
Figure 2: Results of the image analysis of SERT-positive clusters
in blood lymphocytes. (a) Number of clusters per lymphocyte. (b)
Average size of clusters. (c) Percentage of the lymphocyte surface
occupied by SERT-positive clusters.
only a signiﬁcant decrease in the production of IL-4 (but
not in the other parameters) by Reln
+/− mice [29]. At the
time of this publication (1995), there was no evidence of
reelin expression in blood plasma, and so the authors were
discussing the possibility that the alterations found in T-cell
lymphocytes could be related to alterations in the nervous
system (mostly in the cerebellum) of Reln
−/− mice. However,
with the discovery of reelin expression in blood plasma, it
seems more possible that there could be a direct connection
between the decrease of reelin levels in blood plasma and
the alterations observed in T cells in Reln
−/− mice. Our
data shows an increase in SERT clusters size in both Reln
+/−Cardiovascular Psychiatry and Neurology 5
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Figure 3: Representation of the distribution of SERT-positive
clusters size. Note that the peak of clusters size between 0.05–
0.1μm2 isdecreasedintheheterozygousandreelermice,whilethere
is a concomitant increase of larger clusters.
and Reln
−/− mice, although this increase is much higher
in Reln
−/− mice where SERT clusters average size is more
than double of that in Reln
+/+ mice and more than 60%
larger than in Reln
+/− mice. In addition, surface plots of
SERT immunoﬂuorescence appear to indicate a decrease in
the intensity of labeling per cluster that is more pronounced
in Reln
−/− lymphocytes, and the number of SERT-positive
clusters is increased in Reln
+/− mice but not in Reln
−/− mice.
This could be interpreted as an alteration in SERT clustering,
reﬂecting an accumulation of SERT in clusters of small size
in Reln
+/+ mice, while a decrease in reelin expression brings
about the spread out of SERT in clusters of larger size. The
clustering of SERT in lipid raft domains is important for
SERT functional roles [3], and it is possible that a decrease in
reelinlevelscouldbringaboutanalterationofthisclustering.
In Reln
+/− mice, the spread out of SERT in lymphocytes
membranes is much lower than that in Reln
−/− mice, and
in addition there is a 50% increase in the number of SERT
clusters in Reln
+/− mice that could represent a compensatory
mechanism that is not evident in Reln
−/− mice. Both of
these facts could perhaps explain in part the much lower
alterations in T cells in Reln
+/− mice than in Reln
−/− mice
observed by Green-Johnson et al. [29].
Reelin has been shown to induce the expression and
clustering of some transmembrane proteins in synaptosomes
[23], induces the clustering of its own receptors [30], and
regulates NMDA receptor surface traﬃcking [31], therefore,
itis not surprising thatthereis aspreadoutofSERTlabelling
in the membrane of lymphocytes in Reln
+/− and Reln
−/−
mice. In fact, it is possible that reelin may be involved in
regulating the clustering of multiple membrane proteins,
including some neurotransmitter receptors and transporters.
Although brain serotonin levels appear to be unaltered in
Reln
+/− mice, both Reln
+/+ and Reln
+/− mice show an
increase in brain serotonin levels upon early maternal sep-
aration of the pups [32]. In addition, at least in Reln
−/− mice
there are important alterations in serotonergic innervations
in the neocortex [33]. Therefore, we are currently studying
possible alterations in SERT clustering in the brain of these
mice.Reelinisdown-regulated inschizophrenia, autism,and
mooddisorders,showingageneraldecreaseindiﬀerentbrain
areas in schizophrenia, autism, and bipolar disorder, while
there could be a more speciﬁc decrease in major depressive
disorder [11–14]. Reelin levels and its processing are also
altered in blood plasma of schizophrenia, autism, and mood
disorders [14, 17]. Interestingly, brain and plasma reelin lev-
els are highly downregulated in autism [14, 34–38], a disor-
der that is also characterized by blood hyperserotonemia [39,
40]. Taking into account the alterations in SERT clustering
in lymphocytes of reelin-deﬁcient mice shown in this report,
one should consider the possibility of a similar alteration in
lymphocytes of autistic patients that have both low plasma
reelin levels and high plasma serotonin levels. In addition, it
would be of interest to study a possible relation between the
low levels of plasma reelin and the blood hyperserotonemia
observed in these patients, as well as a possible increase in
serotonin levels in blood plasma in reelin-deﬁcient mice.
The results of the present report also invite to consider
the actions of plasma reelin actions in SERT clustering in
lymphocytes as a possible factor of importance in under-
standing the comorbidities between some immune and/or
vascular systems alterations and these mental disorders.
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